BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Vasoactive intestinal polypeptide receptor 2' and Ligand = 'BDBM50445121'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Vasoactive intestinal polypeptide receptor 2


(Homo sapiens (Human))
BDBM50445121
PNG
(CHEMBL3102926)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O |r|
Show InChI InChI=1S/C160H258N46O45/c1-19-22-31-57-159(17,155(250)180-87(14)129(223)201-123(83(8)9)149(243)185-99(43-29-35-61-163)133(227)182-98(42-28-34-60-162)134(228)188-106(68-91-47-51-94(211)52-48-91)139(233)187-104(65-81(4)5)137(231)191-111(73-119(169)216)141(235)198-115(79-208)146(240)202-125(85(12)21-3)151(245)194-105(66-82(6)7)138(232)190-109(71-117(167)214)131(225)177-77-120(217)181-103(154(248)249)44-30-36-62-164)206-148(242)102(55-56-116(166)213)184-132(226)97(41-27-33-59-161)183-135(229)100(45-37-63-175-157(170)171)199-156(251)160(18,58-32-23-20-2)205-147(241)101(46-38-64-176-158(172)173)186-152(246)126(88(15)209)203-143(237)107(69-92-49-53-95(212)54-50-92)189-140(234)110(72-118(168)215)192-142(236)113(75-122(220)221)196-153(247)127(89(16)210)204-144(238)108(67-90-39-25-24-26-40-90)195-150(244)124(84(10)11)200-128(222)86(13)179-136(230)112(74-121(218)219)193-145(239)114(78-207)197-130(224)96(165)70-93-76-174-80-178-93/h19-20,24-26,39-40,47-54,76,80-89,96-115,123-127,207-212H,1-2,21-23,27-38,41-46,55-75,77-79,161-165H2,3-18H3,(H2,166,213)(H2,167,214)(H2,168,215)(H2,169,216)(H,174,178)(H,177,225)(H,179,230)(H,180,250)(H,181,217)(H,182,227)(H,183,229)(H,184,226)(H,185,243)(H,186,246)(H,187,233)(H,188,228)(H,189,234)(H,190,232)(H,191,231)(H,192,236)(H,193,239)(H,194,245)(H,195,244)(H,196,247)(H,197,224)(H,198,235)(H,199,251)(H,200,222)(H,201,223)(H,202,240)(H,203,237)(H,204,238)(H,205,241)(H,206,242)(H,218,219)(H,220,221)(H,248,249)(H4,170,171,175)(H4,172,173,176)/t85-,86-,87-,88+,89+,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,123-,124-,125-,126-,127-,159-,160-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/an/an/a 1.40n/an/an/an/a



AstraZeneca

Curated by ChEMBL


Assay Description
Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assay


ACS Med Chem Lett 4: 1163-8 (2013)


Article DOI: 10.1021/ml400257h
BindingDB Entry DOI: 10.7270/Q27P90V9
More data for this
Ligand-Target Pair